Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $109,305.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA110524-01 | Phase I | 109,305 | ||||||||
A SBIR Phase II contract was awarded to ST. CHARLES PHARMACEUTICALS for $835,120.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS038358-02 | Phase II | 835,120 | ||||||||
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $99,947.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS045371-01 | Phase I | 99,947 | ||||||||
A STTR Phase II contract was awarded to ST. CHARLES PHARMACEUTICALS for $499,068.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AG018196-02A1 | Phase II | 499,068 | ||||||||
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $111,893.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS051880-01A2 | Phase I | 111,893 | ||||||||
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $99,959.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG021828-01 | Phase I | 99,959 | ||||||||
A SBIR Phase II contract was awarded to ST. CHARLES PHARMACEUTICALS for $789,210.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS045371-02 | Phase II | 789,210 | ||||||||
A STTR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $100,000.0 USD from the U.S. Department of Health & Human Services. | STTR | PHS2001-2 | Phase I | 100,000 | ||||||||
A STTR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS from the U.S. Department of Health & Human Services. | STTR | 2R42AG018196-02A1 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $99,278.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS046891-01 | Phase I | 99,278 | ||||||||
A SBIR Phase II contract was awarded to ST. CHARLES PHARMACEUTICALS for $636,256.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2U44NS046891-02 | Phase II | 636,256 | ||||||||
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS from the U.S. Department of Health & Human Services. | SBIR | 2R44NS038358-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to ST. CHARLES PHARMACEUTICALS for $99,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 99,999 |